Literature DB >> 24369025

When the living and the deceased cannot agree on organ donation: a survey of US organ procurement organizations (OPOs).

W J Chon, M A Josephson, E J Gordon, Y T Becker, P Witkowski, D J Arwindekar, A Naik, J R Thistlethwaite, C Liao, L F Ross.   

Abstract

The legal concept of first person authorization (FPA) is based on the principle that a decision by a person with decision-making capacity should be respected even after he or she dies. Although the transplant community largely supports this concept, its implementation has not been universal. We conducted a web-based survey of all 58 Organ Procurement Organization (OPO)executive directors in the United States to assess OPOs' procurement policies and practices in the context of family objections. All 58 respondents(100%) responded to our survey. All OPOs except one have an online donor registration website. Most OPOs(89%) (51 of 57 respondents) estimated that the frequency of family objecting to organ donation in cases of registered donors was <10%. No OPOs reported the frequency to be higher than 25%. Only 50% (27 of 54) of the OPOs have a written policy on handling family objections. Approximately 80% of the OPOs reported honoring FPA. However, in the past 5 years, 20 OPOs (35%) have not yet participated in organ procurement from a registered deceased donor over family objection. Further research to identify the barriers and possible solutions to implementing FPA is warranted.

Entities:  

Mesh:

Year:  2014        PMID: 24369025     DOI: 10.1111/ajt.12519

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  10 in total

1.  Uncontrolled Donation After Circulatory Determination of Death Donors (uDCDDs) as a Source of Lungs for Transplant.

Authors:  T M Egan; J J Requard
Journal:  Am J Transplant       Date:  2015-04-14       Impact factor: 8.086

2.  Evaluating the "family veto" of consent for organ donation.

Authors:  Maeghan Toews; Timothy Caulfield
Journal:  CMAJ       Date:  2016-11-14       Impact factor: 8.262

3.  Organ Procurement Organization Survey of Practices and Beliefs Regarding Prerecovery Percutaneous Liver Biopsy in Donation After Neurologic Determination of Death.

Authors:  Joseph Benton Oliver; Andrea Fleisch Marcus; Mark Paster; Joseph Nespral; Advaith Bongu; George Dikdan; Lloyd Brown; Nikole Neidlinger; Baburao Koneru
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

Review 4.  Informing Consent for Organ Donation.

Authors:  Ryan R Nash; Courtney E Thiele
Journal:  HEC Forum       Date:  2016-09

5.  Current Status of Organ Donation.

Authors:  J E Betsy Tuttle-Newhall; Mark Schnitzler
Journal:  Mo Med       Date:  2015 May-Jun

Review 6.  Two fundamental ethical and legal rules for deceased organ donation.

Authors:  D Gardiner; A McGee; D Shaw
Journal:  BJA Educ       Date:  2021-05-06

7.  Disparities in Deceased Organ Donor Research Authorization: Experience at One Organ Procurement Organization and Call for National Conversations.

Authors:  Krista L Lentine; Cameran Jones; Wisit Cheungpasitporn; Richard Rothweiler; Huiling Xiao; Gary Marklin; Mariella Ortigosa-Goggins; Kathryn K Lindsay; Mark A Schnitzler; Matthew Cooper; Roslyn B Mannon
Journal:  Kidney Int Rep       Date:  2021-06-26

8.  A Qualitative Study in Family Units on Organ Donation: Attitude, Influencing Factors and Communication Patterns.

Authors:  Aijing Luo; Haiyan He; Zehua Xu; Wei Ouyang; Yang Chen; Ke Li; Wenzhao Xie
Journal:  Transpl Int       Date:  2022-03-23       Impact factor: 3.782

9.  Deceased Organ Donation Registration and Familial Consent among Chinese and South Asians in Ontario, Canada.

Authors:  Alvin Ho-Ting Li; Eric McArthur; Janet Maclean; Cynthia Isenor; Versha Prakash; S Joseph Kim; Greg Knoll; Baiju Shah; Amit X Garg
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

10.  Estimating the effect of focused donor registration efforts on the number of organ donors.

Authors:  James H Cardon; Jordan C Holbrook; Mark H Showalter
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.